Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20051
20061
20081
20094
20112
20125
20134
20149
20153
20164
20176
20184
20193
20207
20211
20224
20231
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Terminated11
Recruiting6
Unknown status4
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca17
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Medicago3
National Center for Research Resources (NCRR)3
Novartis Pharmaceuticals3
United Therapeutics3
AO GENERIUM2
Assistance Publique - Hôpitaux de Paris2
Bellus Health Inc. - a GSK company2
BioNTech SE2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases77
Lung Diseases45
Lung Diseases, Obstructive21
Bronchial Diseases18
Asthma16
Respiratory Tract Infections15
Virus Diseases11
Pulmonary Disease, Chronic Obstructive10
Infections9
Lung Neoplasms8

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.